Literature DB >> 15781028

Do elderly systolic heart failure patients benefit from beta blockers to the same extent as the non-elderly? Meta-analysis of >12,000 patients in large-scale clinical trials.

Brian R Dulin1, Steven J Haas, William T Abraham, Henry Krum.   

Abstract

A meta-analysis of all-cause mortality data involving elderly and non-elderly chronic heart failure patients from 5 completed beta-blocker trials revealed that elderly and non-elderly chronic heart failure patients derived considerable prognostic benefit from beta-blocker therapy without a statistically significant difference in mortality reduction between the 2 groups.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15781028     DOI： 10.1016/j.amjcard.2004.11.052

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  22 in total

Review 1.  Systolic heart failure in the elderly: optimizing medical management.

Authors:  Jonathan P Man; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 2.  Aging-associated cardiovascular changes and their relationship to heart failure.

Authors:  James B Strait; Edward G Lakatta
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

Review 3.  Heart rate and blood pressure: any possible implications for management of hypertension?

Authors:  Scott Reule; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 4.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2010-02-25

5.  Pharmacotherapy Use in Older Patients With Heart Failure and Reduced Ejection Fraction After a Skilled Nursing Facility Stay.

Authors:  Lin Li; Bill M Jesdale; Anne Hume; Giovanni Gambassi; Robert J Goldberg; Kate L Lapane
Journal:  J Card Fail       Date:  2017-09-20       Impact factor: 5.712

Review 6.  Heart failure.

Authors:  Robert Samuel McKelvie
Journal:  BMJ Clin Evid       Date:  2011-08-30

Review 7.  Heart failure in elderly patients: distinctive features and unresolved issues.

Authors:  Valentina Lazzarini; Robert J Mentz; Mona Fiuzat; Marco Metra; Christopher M O'Connor
Journal:  Eur J Heart Fail       Date:  2013-02-20       Impact factor: 15.534

Review 8.  Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.

Authors:  Donatella Del Sindaco; Maria Denitza Tinti; Luca Monzo; Giovanni Pulignano
Journal:  Clin Interv Aging       Date:  2010-12-03       Impact factor: 4.458

9.  Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

Authors:  Hans-Dirk Düngen; Svetlana Apostolović; Simone Inkrot; Elvis Tahirović; Florian Krackhardt; Milan Pavlović; Biljana Putniković; Mitja Lainscak; Götz Gelbrich; Frank Edelmann; Rolf Wachter; Thomas Eschenhagen; Finn Waagstein; Ferenc Follath; Mathias Rauchhaus; Wilhelm Haverkamp; Karl-Josef Osterziel; Rainer Dietz
Journal:  Clin Res Cardiol       Date:  2008-06-09       Impact factor: 5.460

Review 10.  Medication management of chronic heart failure in older adults.

Authors:  Kannayiram Alagiakrishnan; Maciej Banach; Linda G Jones; Ali Ahmed; Wilbert S Aronow
Journal:  Drugs Aging       Date:  2013-10       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.